A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61K 31/48 (2006.01) A61K 31/4985 (2006.01) A61P 3/00 (2006.01)
Patent
CA 2254116
This invention is directed to modifying or regulating in a subject of at least one of lipid and glucose metabolism by administering to a subject in need of such treatment a dopamine D1 agonist in conjunction with one agent or agent combination selected from i) a dopamine D2 agonist, ii) at least one of an adrenergic alphal antagonist, an adrenergic alpha2 agonist and a serotonergic inhibitor, or iii) a dopamine D2 agonist further conjoined with at least one of an adrenergic alphal antagonist, an adrenergic alpha2 agonist and a serotonergic inhibitor.
Cette invention a trait à la modification ou à la régulation, chez un sujet, soit du métabolisme des lipides, soit de celui du glucose, par l'administration au sujet exigeant un tel traitement, d'un agoniste de la dopamine D1 et ce, concurremment à un agent ou à une combinaison d'agents choisis dans le groupe constitué des substances suivantes: (i), un agoniste de la dopamine D2, (ii), un antagoniste alpha-1 adrénergique, un agoniste alpha-2 adrénergique ou un inhibiteur sérotoninergique ou bien (iii), un agoniste de la dopamine D2 associé, par ailleurs, à un antagoniste alpha-1 adrénergique ou à un agoniste alpha-2 adrénergique ou à un inhibiteur sérotoninergique.
Ergo Research Corporation
Robic
Veroscience Llc
LandOfFree
Method and composition for the treatment of lipid and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for the treatment of lipid and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for the treatment of lipid and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1843703